Morepen Logo
Morepen Logo
  • Home
  • About Morepen
  • Business Segment
  • Research & Development
  • Investors
  • Media Kit
  • Contact Us
  • Company Profile
  • Mission & Values
  • Our History
  • Leadership
    • Board of Directors
    • Management Team
  • Morepen Presence
  • Company Social Responsibility
  • Environment Monitoring
  • Active Pharmaceutical Ingredients
    • Overview
    • Product Information
    • Intermediate
    • Drug Master Files
    • Regulated Market
    • Non Regulated Market
  • Formulations
    • Overview
    • Branded Prescription Drugs
    • Catalogue
  • Diagnostics
    • Overview
    • Home Health
    • Clinical Diagnostics
    • Service / Demo Request
  • Dr. Morepen
    • Overview
    • Products
  • Overview
  • Product in Development
  • Chemistry Skills
  • Quality Control
  • Manufacturing Facilities
    • Masulkhana
    • Parwanoo
    • Baddi
  • Financial Results
  • Share Holding Pattern
  • Code of Conduct
  • Green Initiative
  • News Room
  • Videos
  • News Room
  • Video
  • Picture Gallery

Home > Media KIt > News Room

News Rooms

Unaudited Financial Results for the Quarter ended 30th September, 2008
Shareholding Pattern as on 30th June 2008
Unaudited Financial Results for the Quarter ended 30th June, 2008
Audited Financial Results for the Year ended 31st March, 2008
Shareholding Pattern as on 31st March 2008
Shareholding Pattern as on 31st December 2007
Unaudited Financial Results for the Quarter ended 31st December, 2007
Unaudited Financial Results for the Quarter ended 30th September, 2007
MOREPEN SIGNS EQUITY DEAL WITH AVENUE WILL PAY OFF ALL CDR BANKS
Unaudited Financial Results for the Quarter ended 30th June, 2007
MOREPEN STARTS DEBT SETTLEMENT Issues Fresh Capital of Rs.103 crores
DR. MOREPEN GETS RESTRAINT ORDER AGAINST ‘LEMOTAB’
 
Previous Page

 

Home | Contact Us | Sitemap
© Copyright 2010. All Rights Reserved.